- Patent Title: Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
-
Application No.: US15856922Application Date: 2017-12-28
-
Publication No.: US10400043B2Publication Date: 2019-09-03
- Inventor: Christine A. White , Antonio J. Grillo-Lopez
- Applicant: Biogen Inc.
- Applicant Address: US MA Cambridge
- Assignee: Biogen, Inc.
- Current Assignee: Biogen, Inc.
- Current Assignee Address: US MA Cambridge
- Agent Wendy M. Lee
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/573 ; A61K31/704 ; A61K31/664 ; C07K16/28 ; A61K31/475 ; A61K31/675 ; A61K35/28 ; A61K35/545 ; A61K39/00
Abstract:
The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
Public/Granted literature
- US20180118844A1 TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY Public/Granted day:2018-05-03
Information query
